ArticleOncology research and treatment2020

Patient Characteristics and Outcomes of Relapsed/Refractory Multiple Myeloma in Patients Treated with Proteasome Inhibitors in Germany.

H Tilman Steinmetz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.